Twin Tree Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Twin Tree Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-500	Closed	-$82K	–	1486
2021 Q1	$82K	Buy	+500	New	+$82.3K	﹤0.01%	1186
2018 Q2	–	Sell	-500	Closed	-$75K	–	1250
2018 Q1	$75K	Buy	+500	New	+$73.3K	﹤0.01%	984
2016 Q4	–	Sell	-7,800	Closed	-$948K	–	1261
2016 Q3	$948K	Hold	7,800	–	–	0.01%	691
2016 Q2	$1.1M	Buy	+7,800	New	+$1.15M	0.02%	632
2015 Q2	–	Sell	-3,400	Closed	-$587K	–	1401
2015 Q1	$587K	Sell	3,400 -11,700	-77%	-$2.01M	0.02%	748
2014 Q4	$2.47M	Buy	+15,100	New	+$2.51M	0.07%	318

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Twin Tree Management's JAZZ Position: Q3 2021 in Review

Twin Tree Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 16,974 shares — an estimated $2.56M sold.

Twin Tree Management first reported a position in JAZZ in Q4 2014 and held it in 19 quarters. The position peaked at $3.02M in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

Twin Tree Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Twin Tree Management sold 16,974 Jazz Pharmaceuticals shares in Q3 2021, an estimated $2.56M.
Twin Tree Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 19 quarters.
Twin Tree Management's Jazz Pharmaceuticals position peaked at $3.02M in Q2 2021.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Twin Tree Management's 13F filing for Q3 2021, filed 12 Nov 2021.